Integrating Current Guideline Recommendations in Practice for the Management of T2DM: A Quality Improvement Initiative


This activity will review the cardiovascular outcomes data for SGLT-2 inhibitors and GLP-1 receptor agonists. A panel of expert faculty will discuss current guideline recommendations and discuss how to integrate the latest CV outcomes data in practice for the management of type 2 diabetes patients and patients with heart failure or kidney disease to ensure guideline concordant care and optimize outcomes.  

Target Audience
Endocrinologists, cardiologists, primary care providers (IM/FP/GP - NP/PA) along with RNs and other health professionals engaged in the care of patients with hypertriglyceridemia, diabetes, or heart failure.  

Learning Objectives
  1. Review current CVD outcomes data for the treatment of patients with T2DM

  2. Outline current guideline recommendations for the treatment of T2DM

  3. Individualize treatment for patients with T2DM and ASCVD to ensure guideline-concordant care 

  4. Describe the benefits & risks of novel antihyperglycemic agents to ensure patient adherence

Activity Launch Date - 11/25/20
Expiration Date - 11/25/21

Disclosure of Commercial Support
This activity is supported by an independent medical education grant from AstraZeneca Pharmaceuticals LP.

Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. 
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners.  Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.

Statement of Independence
Horizon CME educational activities are developed and conducted in accordance with the ACCME's Essential Areas and Policies.  It is the mission of Horizon CME to develop and present educational activities that are timely, fair balanced, scientifically rigorous, and that serve to improve patient outcomes.  To that end, we welcome comments about how to better serve your needs.

Copyright Information
© 2020 by Horizon CME.  All rights reserved.  No part of this accredited continuing education activity may be reproduced or transmitted in any form or by any means, electronic or mechanical, without first obtaining permission from Horizon CME.